ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,644Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 174

$792K Total Retail Price of All Prescriptions

Rank: 9 out of 174

486 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 486 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

16% of this provider’s 486 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

2% of this provider’s 9,976 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 59%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $173 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
FUROSEMIDE 520 470 1 12
AMLODIPINE BESYLATE 513 440 2 17
HYDROCODONE-ACETAMINOPHEN 365 284 S3 3 13
OMEPRAZOLE 355 316 4 11
POTASSIUM CHLORIDE 304 266 5 24
SIMVASTATIN 299 262 6 14
LEVOTHYROXINE SODIUM 287 271 7 19
ATORVASTATIN CALCIUM 265 211 8 27
PRAVASTATIN SODIUM 229 213 9 34
TRAMADOL HCL 225 213 10 39
LISINOPRIL 204 190 11 18
ALENDRONATE SODIUM 193 181 12 44
METFORMIN HCL 189 158 13 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 167 145 14 63
CARVEDILOL 150 141 15 45
ADVAIR DISKUS 149 125 16 2
SPIRIVA 141 126 17 1
NEXIUM 136 112 18 28
PANTOPRAZOLE SODIUM 134 122 19 38
SINGULAIR 127 96 20 9
KLOR-CON M20 126 86 21 50
GABAPENTIN 124 107 22 33
ZOLPIDEM TARTRATE 124 95 22 16
DIOVAN HCT 111 98 24 75
METOPROLOL SUCCINATE 107 78 25 48
WARFARIN SODIUM 104 96 26 23
GLIPIZIDE 100 87 27 82
CYMBALTA 97 86 28 91
CRESTOR 94 86 29 62
KLOR-CON 10 93 85 30 94
PREDNISONE 93 71 30 3
ALLOPURINOL 91 82 32 61
DIGOXIN 91 91 32 68
HYDROCHLOROTHIAZIDE 90 82 34 29
COMBIVENT 90 77 34 7
METOPROLOL TARTRATE 85 85 36 37
TRAZODONE HCL 84 70 37 64
ATENOLOL 84 61 37 30
MELOXICAM 80 55 39 71
JANUVIA 78 69 40 79
LOVASTATIN 77 63 41 125
THEOPHYLLINE ANHYDROUS 76 63 42 21
SPIRONOLACTONE 75 49 43 67
FLUOXETINE HCL 72 50 44 81
AZITHROMYCIN 72 55 44 8
CARISOPRODOL 71 26 R 46 53
GLIMEPIRIDE 71 60 46 98
GLYBURIDE 71 59 R 46 73
MONTELUKAST SODIUM 69 52 49 15
TAMSULOSIN HCL 69 58 49 59
LANTUS 68 65 51 95
ENALAPRIL MALEATE 67 67 52 88
LOSARTAN POTASSIUM 62 59 53 35
SYMBICORT 58 46 54 5
CLOPIDOGREL 57 42 55 78
FLUTICASONE PROPIONATE 57 33 55 10
LIPITOR 53 43 57 88
BENAZEPRIL-HYDROCHLOROTHIAZIDE 52 41 58 140
BENICAR HCT 51 51 59 146
TRICOR 51 51 59 146
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 17, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.